Cyanotic heart defect: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
'''Associate Editor-in-Chief:''' Keri Shafer, M.D. [mailto:kshafer@bidmc.harvard.edu] | '''Associate Editor-in-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu] | ||
{{Editor Join}} | {{Editor Join}} | ||
Revision as of 21:34, 7 January 2009
| Cyanotic heart defect |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-in-Chief: Keri Shafer, M.D. [2]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
- Tetralogy of Fallot (ToF)
- Total anomalous pulmonary venous connection
- Hypoplastic left heart syndrome (HLHS)
- Transposition of the great arteries (d-TGA)
- Truncus arteriosus (Persistent)
- Tricuspid atresia
- Interrupted aortic arch
- Coarctation of aorta
- Tricuspid atresia
- Pulmonary atresia (PA)
- Pulmonary stenosis (advanced)